Hal Mintz, Sabby Management Report 7.43% Stake in Oxygen Biotherapeutics, Inc. (OXBT)

Hal Mintz‘ Sabby Management has reported a new stake in the biotechnology company Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), a new filing with the SEC shows. Sabby currently owns over 1.96 million shares of the company, equal to 7.43% of the outstanding stock. The value of the passive position amounts to around $11.61 million, at the current price of the company’s stock.

Oxygen Biotherapeutics

Interestingly, Sabby Management purchased the shares of Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), after disclosing in its latest 13F filing, dumping the holding, which previously contained some 36,700 shares. Out of the funds that we track, Ellington, led by Mike Vranos, is the only one that disclosed holding Oxygen Biotherapeutics in its equity portfolio as at the end of last year. Ellington’s stake amasses 34,200 shares, with a reported value of $154,000.

Sabby’s latest acquisition falls in line with the recently announced public offering launched by Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT). The company intends to sell around $52 million worth of stock, for a price of $5.60 per share, Oxygen Biotherapeutics said in a statement. The proceeds will be used for company’s clinical trials as well as for obtaining regulatory approvals for two of its drugs: Levosimendan and Oxycyte. In addition the company will also spend the cash it receives from the proceeds to support the manufacturing of the aforementioned drugs and for development of other product candidates, the statement added.

Moreover, at the beginning of March, Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) announced that its Oxycyte drug has been reviewed by U.S. FDA agency, which decided to lift the clinical hold of the drug, which means a green light for the clinical development of the product in the U.S, another press release said.

On the back of positive news related to the development of the company, the stock of Oxygen Biotherapeutics has been gaining ground since the beginning of the year, and is already 30% year-to-date.

Recently, Sabby Management disclosed adding other two Healthcare stocks to its equity portfolio. The fund disclosed ownership of 437,500 shares of Recro Pharma Inc (NASDAQ:REPH) and 1.7 million shares of Bioline RX Ltd (NASDAQ:BLRX), both stakes amassing around 5% of the companies’.

Disclosure: none

Recommended Reading:

RA Capital Discloses New Passive Stake in Repros Therapeutics Inc (RPRX)

Steven Cohen Ups His Bets on NQ Mobile Inc (ADR) (NQ)

Himanshu H. Shah Ups Stake in Corinthian Colleges Inc (COCO); Sends Letter to the Board

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!